- Home
- BHST vs WLGS Comparison
BHST vs WLGS Comparison
Compare BHST & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHST
- WLGS
- Stock Information
- Founded
- BHST 2007
- WLGS 1981
- Country
- BHST Canada
- WLGS Hong Kong
- Employees
- BHST N/A
- WLGS N/A
- Industry
- BHST
- WLGS Engineering & Construction
- Sector
- BHST
- WLGS Consumer Discretionary
- Exchange
- BHST Nasdaq
- WLGS Nasdaq
- Market Cap
- BHST 106.0M
- WLGS 98.9M
- IPO Year
- BHST N/A
- WLGS 2023
- Fundamental
- Price
- BHST $6.46
- WLGS $0.27
- Analyst Decision
- BHST Strong Buy
- WLGS
- Analyst Count
- BHST 2
- WLGS 0
- Target Price
- BHST $13.00
- WLGS N/A
- AVG Volume (30 Days)
- BHST 11.2K
- WLGS 4.5M
- Earning Date
- BHST 03-31-2025
- WLGS 04-08-2025
- Dividend Yield
- BHST N/A
- WLGS N/A
- EPS Growth
- BHST N/A
- WLGS N/A
- EPS
- BHST N/A
- WLGS 0.02
- Revenue
- BHST $22,430,000.00
- WLGS $7,272,879.00
- Revenue This Year
- BHST $161.11
- WLGS N/A
- Revenue Next Year
- BHST $64.74
- WLGS N/A
- P/E Ratio
- BHST N/A
- WLGS $14.79
- Revenue Growth
- BHST 111.68
- WLGS 66.93
- 52 Week Low
- BHST $0.00
- WLGS $0.23
- 52 Week High
- BHST $7.38
- WLGS $9.66
- Technical
- Relative Strength Index (RSI)
- BHST N/A
- WLGS 27.50
- Support Level
- BHST N/A
- WLGS $0.23
- Resistance Level
- BHST N/A
- WLGS $5.85
- Average True Range (ATR)
- BHST 0.00
- WLGS 0.52
- MACD
- BHST 0.00
- WLGS -0.41
- Stochastic Oscillator
- BHST 0.00
- WLGS 0.69
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.